A letter to the editor is presented which discusses a study of the inhibition of melanogenesis by dopamine D4 receptor antagonist (DRD4A) through transcriptional downregulation of microphthalmia-associated transcription factor (MITF) through extracellular signal-regulated kinase (ERK) pathways.